Lexicon Pharmaceuticals Inc’s recently made public that its Former Affiliate COATS LONNEL acquired Company’s shares for reported $0.48 million on Aug 15 ’24. In the deal valued at $1.60 per share,300,000 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, COATS LONNEL bought 90,000 shares, generating $94,797 in total proceeds. Upon buying the shares at $1.05, the Chief Executive Officer now owns 914,359 shares.
Before that, COATS LONNEL bought 10,000 shares. Lexicon Pharmaceuticals Inc shares valued at $10,100 were divested by the Chief Executive Officer at a price of $1.01 per share. As a result of the transaction, COATS LONNEL now holds 824,359 shares, worth roughly $1.67 million.
H.C. Wainwright initiated its Lexicon Pharmaceuticals Inc [LXRX] rating to a Buy in a research note published on June 17, 2024; the price target was $10. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Jefferies began covering LXRX with “Hold” recommendation on March 07, 2023. Piper Sandler started covering the stock on August 12, 2022. It rated LXRX as “an Overweight”.
Price Performance Review of LXRX
On Tuesday, Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] saw its stock jump 9.14% to $2.03. Over the last five days, the stock has gained 4.64%. Lexicon Pharmaceuticals Inc shares have risen nearly 32.68% since the year began. Nevertheless, the stocks have risen 82.88% over the past one year. While a 52-week high of $3.73 was reached on 02/16/24, a 52-week low of $0.92 was recorded on 01/19/24. SMA at 50 days reached $1.7200, while 200 days put it at $1.9100.
Levels Of Support And Resistance For LXRX Stock
The 24-hour chart illustrates a support level at 1.8900, which if violated will result in even more drops to 1.7500. On the upside, there is a resistance level at 2.1200. A further resistance level may holdings at 2.2200. The Relative Strength Index (RSI) on the 14-day chart is 64.45, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0200, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.22%. Stochastics %K at 51.59% indicates the stock is a holding.
How much short interest is there in Lexicon Pharmaceuticals Inc?
A steep rise in short interest was recorded in Lexicon Pharmaceuticals Inc stocks on 2024-10-15, growing by 1.02 million shares to a total of 27.65 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 26.63 million shares. There was a rise of 3.7%, which implies that there is a positive sentiment for the stock.
